Alliancebernstein L.P. Eagle Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $352,294 - $529,946	-23,162 Reduced 51.99%	21,390 $337,000
Q2 2023 Aug 15, 2023	BUY	$17.74 - $31.87 $45,325 - $81,427	2,555 Added 6.08%	44,552 $866,000
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $38,517 - $52,396	-1,537 Reduced 3.53%	41,997 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $99,370 - $158,205	3,978 Added 10.06%	43,534 $1.27 Million
Q3 2022 Nov 15, 2022	SELL	$26.42 - $47.12 $8,031 - $14,324	-304 Reduced 0.76%	39,556 $1.05 Million
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $3,672 - $4,570	-89 Reduced 0.22%	39,860 $1.77 Million
Q1 2022 May 13, 2022	SELL	$44.58 - $52.6 $34,950 - $41,238	-784 Reduced 1.92%	39,949 $1.98 Million
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $504 - $625	11 Added 0.03%	40,733 $2.07 Million
Q3 2021 Nov 10, 2021	SELL	$43.79 - $55.78 $68,181 - $86,849	-1,557 Reduced 3.68%	40,722 $2.27 Million
Q2 2021 Jul 30, 2021	BUY	$36.86 - $44.5 $263,807 - $318,486	7,157 Added 20.38%	42,279 $1.81 Million
Q1 2021 May 06, 2021	BUY	$40.32 - $50.97 $265,708 - $335,892	6,590 Added 23.1%	35,122 $1.47 Million
Q4 2020 Feb 08, 2021	SELL	$41.72 - $51.34 $70,924 - $87,278	-1,700 Reduced 5.62%	28,532 $1.33 Million
Q3 2020 Nov 12, 2020	SELL	$37.02 - $51.28 $176,141 - $243,990	-4,758 Reduced 13.6%	30,232 $1.28 Million
Q2 2020 Aug 13, 2020	SELL	$43.24 - $55.02 $2,162 - $2,751	-50 Reduced 0.14%	34,990 $1.68 Million
Q1 2020 May 14, 2020	SELL	$34.37 - $60.07 $20,622 - $36,042	-600 Reduced 1.68%	35,040 $1.61 Million
Q4 2019 Feb 18, 2020	BUY	$54.32 - $64.31 $5,432 - $6,431	100 Added 0.28%	35,640 $2.14 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $127,800 - $143,952	-2,400 Reduced 6.33%	35,540 $2.01 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $41,016 - $51,436	880 Added 2.37%	37,940 $2.11 Million
Q1 2019 May 14, 2019	SELL	$38.66 - $51.82 $158,506 - $212,462	-4,100 Reduced 9.96%	37,060 $1.87 Million
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $97,675 - $180,161	-2,660 Reduced 6.07%	41,160 $1.66 Million
Q3 2018 Nov 08, 2018	BUY	$66.65 - $83.86 $1,333 - $1,677	20 Added 0.05%	43,820 $3.04 Million
Q2 2018 Aug 13, 2018	BUY	$51.25 - $76.62 $1.32 Million - $1.97 Million	25,682 Added 141.75%	43,800 $3.31 Million
Q1 2018 May 14, 2018	SELL	$52.16 - $66.86 $729,822 - $935,505	-13,992 Reduced 43.58%	18,118 $955,000
Q4 2017 Feb 13, 2018	BUY	$49.6 - $60.87 $178,560 - $219,132	3,600 Added 12.63%	32,110 $1.72 Million
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $1.33 Million - $1.72 Million	28,510	28,510 $1.7 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account